Abstract
Human platelets possess specific high-affinity binding sites for 3H-imipramine which have similar characteristics to the sites previously described in human and animal brain. In a group of untreated depressed patients, the Bmax of 3H-imipramine binding and the V max of serotonin uptake in their platelets were found to be significantly lower than in a group of control volunteers. There was no significant difference in the K d values for 3H-imipramine binding but the K m values of 3H-serotonin uptake were decreased in the depressed patients. When the measurements of 3H-imipramine binding and 3H-serotonin uptake were compared in the same individual, however, there was no correlation between the individual B max and V max values or the K d and K m values. These results suggest that although the 3H-imipramine binding site and the mechanism for serotonin uptake are associated, they are not identical.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ahtee L, Pentikäinen L, Pentikäinen P, Paasonen M (1974) 5-hydroxytryptamine in the blood platelets of cirrhotic and hypertensive patients. Experientia 30:1328–1329
Ahtee L, Briley M, Raisman R, Lebrec D, Langer SZ (1981) Reduced uptake of serotonin but unchanged 3H-imipramine binding in the platelets from cirrhotic patients. Life Sci 29:2323–2329
Asarch B, Shih J, Kulcsar A (1981) Decreased 3H-imipramine binding in depressed males and females. Commun Psychopharmacol 4:425–432
Born G, Grignani G, Martin K (1980) Long-term effect of lithium on the uptake of 5-hydroxytryptamine by human platelets. Br J Pharmacol 9:321–325
Briley MS, Raisman R, Langer SZ (1979) Human platelets possess high-affinity binding sites for 3H-imipramine. Eur J Pharmacol 58:347–348
Briley MS, Langer SZ, Raisman R, Sechter D, Zarifian E (1980) 3H-imipramine binding sites are decreased in platelets of untreated depressed patients. Science 209:303–305
Briley M, Langer SZ, Sette M (1982) Allosteric interaction between the 3H-imipramine binding site and the serotonin uptake mechanism. Br J Pharmacol 74:817P-818P
Coppen A, Swade C, Wood K (1980) Lithium restores abnormal platelets 5-HT transport in patients with affective disorders. Br J Psychiatry 136:235–238
Da Prada M, Pieri L, Keller H, Pieri M, Bonetti E (1978) Effects of 5,6-dihydroxytryptamine on rat central nervous system after intraventricular or intracerebral application and on blood platelets in vitro. Ann NY Acad Sci 305:395–420
Dumbrille-Ross A, Tang SW (1981) Absence of high-affinity 3H-imipramine binding in platelets and cerebral cortex of Fawn-Hooded rats. Eur J Pharmacol 72:137–138
Giret M, Launay JM, Loo H, Dreux C, Benyacoub A, Zarifian E (1980) Modifications of biochemical parameters in blood platelets of schizophrenic and depressive patients. Neuropsychobiology 6: 290–296
Langer SZ, Moret C, Raisman R, Dubocovich ML, Briley M (1980a) High-affinity 3H-imipramine binding in rat hypothalamus is associated with the uptake of serotonin but not norepinephrine. Science 210:1133–1135
Langer SZ, Briley MS, Raisman R, Henry J-F, Morselli PL (1980b) Specific 3H-imipramine binding in human platelets: Influence of age and sex. Naunyn-Schmiedeberg's Arch Pharmacol 313:189–194
Langer SZ, Briley M (1981) High-affinity 3H-imipramine binding: a new biological tool for studies in depression. Trends in Neurosciences 4:28–31
Langer SZ, Zarifian E, Briley M, Raisman R, Sechter D (1981) High-affinity binding of 3H-imipramine in brain and platelets and its relevance to the biochemistry of affective disorders. Life Sci 29:211–220
Lineweaver A, Burk D (1934) The determination of enzyme dissociation constants. J Am Chem Soc 56:658–666
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Palkovits M, Raisman R, Briley M, Langer SZ (1981) Regional distribution of 3H-imipramine binding in rat brain. Brain Res 210:493–498
Paul SM, Rehavi M, Skolnick P, Goodwin FK (1981) Demonstration of specific high affinity binding sites for 3H-imipramine in human brain and platelets. Proc. 12th CINP Congress, Pergamon Press, New York (in press)
Raisman R, Briley M, Langer SZ (1979) High-affinity 3H-imipramine binding in rat cerebral cortex. Eur J Pharmacol 54:307–308
Raisman R, Sechter D, Briley M, Zarifian E, Langer SZ (1981) High-affinity 3H-imipramine binding in platelets from untreated and treated depressed patients compared to healthy volunteers. Psychopharmacology 75:368–371
Rotman A, Modai I, Munitz H, Wijsenbeek H (1979) Active uptake of serotonin by blood platelets of schizophrenic patients. FEBS Lett 101:134–136
Sette M, Raisman R, Briley M, Langer SZ (1981) Localisation of tricyclic antidepressant binding sites on serotonin nerve terminals in rat hypothalamus. J Neurochem 37:40–42
Shaw DM, MacSweeney DA, Woolcock N, Bevan-Jones AB (1971) Uptake and release of 14C-hydroxytryptamine by platelets in affective illness. J Neurol Neurosurg Psychiatry 34:224–225
Smith CB, Garcia Sevilla JA (1982) Alpha2-adrenoceptors in endogenous depression. In: Langer SZ, Takahashi R, Segawa T, Briley M (eds) New vistas in depression. Pergamon, Oxford, pp 99–106
Tuomisto J, Tukiainen E (1976) Decreased uptake of 5-hydroxytryptamine in blood platelets from depressed patients. Nature 262:596–598
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Raisman, R., Briley, M.S., Bouchami, F. et al. 3H-Imipramine binding and serotonin uptake in platelets from untreated depressed patients and control volunteers. Psychopharmacology 77, 332–335 (1982). https://doi.org/10.1007/BF00432765
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00432765